Children with Cancer UK announces appointment of new trustee and scientific advisor

Five year research strategy

Children with Cancer UK has also recently announced the publication of its plans through its five year research strategy from 2022 until 2027.  The charity said that it would be building on its previous research success which includes the development of a breakthrough molecular technique for measuring Minimal Residual Disease (MRD), subsequently adopted by the NHS as part of the standard treatment for all children with Acute Lymphoblastic Leukaemia.

Jo Elvin, CEO of Children with Cancer UK said of the strategy

We are incredibly proud of what has been achieved by the projects we have funded over the last three decades. We feel confident about this next phase which will focus on the continuation of vital research. Since its launch in 1988, Children with Cancer UK has raised more than £290 million and funded over 300 research projects which has contributed to childhood cancer survival rates improving from 67% to 84%*.   Thanks to the generosity of donors, Children with Cancer UK’s funds will continue to bring together some of the world’s greatest scientific minds whose experience, knowledge, insights and long term commitment will take us ever closer to the charity’s aim of living in a world where every single child and young person survives cancer.

Research that Children with Cancer UK is currently funding includes working on more targeted, less toxic treatment options as well as support of clinical and laboratory research aimed at improving survival and quality-of-life for children and young people. Included in the strategy is the charity’s commitment to continuing its valued collaborations with other charities, universities and organisations which have proved very successful over the last 30 years. The charity will also continue to support the next generation of clinician scientists and research leaders, encouraging their long-term career progression through a number of dedicated programmes.

-ends-

  For more information about Professor Bruce Morland, Professor Pamela Kearns, the five year research strategy or images please contact: Hannah Chambers hannah.chambers@childrenwithcancer.org.uk